Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06625931 |
| Consolidated Lead Sponsor | Yuhan |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 60 participants (ACTUAL) |
| Registered Start Date | 2024-11-14 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Keimyung University, Dongsan hospital | Daegu, South Korea | Open Hospital Dossier -> |
| Seoul National University Hospital | Seoul, South Korea | Open Hospital Dossier -> |
| The Catholic University of Korea, Seoul St. Mary's Hospital | Seoul, South Korea | Open Hospital Dossier -> |
| Korea University Anam Hospital | Seoul, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.